ConductScience.org, home

Paper3904233

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Wilson AJ and 9 others. World J Surg, 1985. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Papers, record 3904233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3904233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
PubMed
Journal
World J Surg
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2019-08-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson AJA J
2Baum MM
3Brinkley DMD M
4Dossett JAJ A
5McPherson KK
6Patterson JSJ S
7Rubens RDR D
8Smiddy FGF G
9Stoll BAB A
10Richards DD

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
TamoxifenMajor topic
Adult
Aged
Clinical Trials as Topic
Combined Modality Therapy
Female
Humans
Mastectomy
Middle Aged

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16729217Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level.Recent Results Cancer Res1984https://conductscience.org/library/papers/6729217PubMed
26144842Long-term survival of women with breast cancer.Lancet1984https://conductscience.org/library/papers/6144842PubMed
36341335Chemotherapy of breast cancer: current views and results.Int J Radiat Oncol Biol Phys1983https://conductscience.org/library/papers/6341335PubMed
42856949Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.Lancet1985https://conductscience.org/library/papers/2856949PubMed
56403101Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6403101PubMed
66696816Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.Br J Cancer1984https://conductscience.org/library/papers/6696816PubMed
76994873The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.Cancer1980https://conductscience.org/library/papers/6994873PubMed
83883168Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med1985https://conductscience.org/library/papers/3883168PubMed
97066649Adjuvant tamoxifen therapy for early breast cancer: an experimental study with reference to oestrogen and progesterone receptors.Br J Surg1982https://conductscience.org/library/papers/7066649PubMed
106150246Review of mortality results in randomised trials in early breast cancer.Lancet1984https://conductscience.org/library/papers/6150246PubMed
115965580Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes.Nature1966https://conductscience.org/library/papers/5965580PubMed
12870163Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer.Cancer1977https://conductscience.org/library/papers/870163PubMed
136130291Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.Lancet1983https://conductscience.org/library/papers/6130291PubMed
145115829A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.Br J Cancer1971https://conductscience.org/library/papers/5115829PubMed
156135926Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.Lancet1983https://conductscience.org/library/papers/6135926PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
21966433Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.PLoS One2011https://conductscience.org/library/papers/21966433PubMed
16734724DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.Cancer Sci2006https://conductscience.org/library/papers/16734724PubMed
12841865The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.Cancer Sci2003https://conductscience.org/library/papers/12841865PubMed
10895801Gynecologic effects of tamoxifen: case reports and review of the literature.Int Urogynecol J Pelvic Floor Dysfunct1996https://conductscience.org/library/papers/10895801PubMed
3620714Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?Breast Cancer Res Treat1987https://conductscience.org/library/papers/3620714PubMed
3543533The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.Med Oncol Tumor Pharmacother1986https://conductscience.org/library/papers/3543533PubMed
3219274Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.Br J Cancer1988https://conductscience.org/library/papers/3219274PubMed
2900646Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.Br J Cancer1988https://conductscience.org/library/papers/2900646PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3904233

GET https://conductscience.org/api/papers/v1/3904233/authors